gray cas - CAS号查询

gadolinium;
GadoliniumpowderNREOmesh;
GadoliniumchipsNREOgraypieces;
GadoliniumingotNREO;
GadoliniumfoilNREOmmthickcagmmxmm;
Gadoliniumpowder;
Gadoliniumchips;
Gadoliniumingot;
Gadoliniumfoil;
Gadolinium

详情

供应商

28894-73-7

grayanotoxane-5,6,10,14,16-pentol,2,3-epoxy-, 14-(2-hydroxypropanoate), (2b,3b,6b,14R)-;
Lacticacid, 2,3-epoxytetradecahydro-4,8,11,11a-tetrahydroxy-1,1,4,8-tetramethyl-7,9a-methano-9aH-cyclopenta[b]heptalen-12-ylester, (2R,3S,3aS,4R,4aR,7R,8R,9aS,11R,11aR,12R)- (8CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxane-5,6,10,14,16-pentol deriv.;
7,9a-Methano-9aH-cyclopenta[b]heptalene-4,8,11,11a,12(1H)-pentol,2,3-epoxydodecahydro-1,1,4,8-tetramethyl-, 12-lactate,(2R,3S,3aS,4R,4aR,7R,8R,9aS,11R,11aR,12R)- (8CI);
7,9a-Methano-9aaH-cyclopenta[b]heptalene-4,8,11,11ab,12(1H)-pentol, 2b,3b-epoxy-2,3,3ab,4,4ab,5,6,7b,8,9,10,11a-dodecahydro-1,1,4b,8b-tetramethyl-, 12-lactate (8CI);
Asebotoxin III

木藜芦毒素?1/2乙酸加成化合物

grayanotoxane-3,5,6,10,14,16-hexol,(3b,6b,14R)-;
grayanotoxinIII (6CI,7CI);
(-)-grayanotoxin III;
Andromedol;
Deacetylandromedotoxin;
Deacylasebotoxin I;
FDA 1962;
NSC 323778

grayanotoxane-3,5,6,10,14,16-hexol,6,14-diacetate, (3b,6b,14R)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxane-3,5,6,10,14,16-hexol deriv.;
6-O-Acetylgrayanotoxin I;
grayanotoxin III 6,14-diacetate;
Rhodojaponin IV

grayanotoxane-5,6,10,14,16-pentol,2,3-epoxy-, 14-propanoate, (2b,3b,6b,14R)- (9CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxane-5,6,10,14,16-pentol deriv.;
Arichannatoxin I

grayanotoxan-7-one,6-(acetyloxy)-2,3-epoxy-5,10,16-trihydroxy-, (2b,3b,6b)- (9CI);
7,9aa-Methano-9aH-cyclopenta[b]heptalene-10(1H)-one,2b,3b-epoxy-2,3,3ab,4,4ab,5,6,7b,8,9,10,11-dodecahydro-4a,8a,11b,11ab-tetrahydroxy-1,1,4,8-tetramethyl-,11-acetate (8CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxan-7-one deriv.;
7-Ketolyoniol A;
Ketolyoniol A

grayanotoxa-10(20),16-diene-3,5,6,14-tetrol,(3b,6b,14R)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene-2,11,11a,12(1H)-tetrol,dodecahydro-1,1-dimethyl-4,8-dimethylene-, (2S,3aS,4aS,7S,9aR,11R,11aR,12R)-(8CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxa-10(20),16-diene-3,5,6,14-tetrol deriv.;
grayanotoxin VIII

grayanotoxane-5,6,7,10,16-pentol,2,3-epoxy-, 7-acetate, (2b,3b,6b,7a)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene-4,8,10,11,11a(1H)-pentol,2,3-epoxydodecahydro-1,1,4,8-tetramethyl-, 11-acetate,(2R,3S,3aS,4R,4aR,7R,8R,9aR,10S,11R,11aR)- (8CI);
Lyoniatoxin (6CI,7CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxane-5,6,7,10,16-pentol deriv.;
Lyoniol A

grayanotox-10(20)-ene-3,5,6,16-tetrol,(3b,6b)-;
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotox-10(20)-ene-3,5,6,16-tetrol deriv.;
grayanotoxin XVIII

grayanotoxane-5,6,10,14,16-pentol,2,3-epoxy-, (2b,3b,6b,14R)-;
7,9a-Methano-9aaH-cyclopenta[b]heptalene-4,8,11,11ab,12(1H)-pentol, 2b,3b-epoxy-2,3,3ab,4,4ab,5,6,7b,8,9,10,11a-dodecahydro-1,1,4b,8b-tetramethyl- (8CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxane-5,6,10,14,16-pentol deriv.;
Rhodojaponin III

grayanotoxane-5,6,10,14,16-pentol,2,3-epoxy-, 6-acetate, (2b,3b,6b,14R)- (9CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxane-5,6,10,14,16-pentol deriv.;
Rhodojaponin II;
Rhodojaponin III6-acetate;
Rhodojaponin III, 9-acetate

grayanotoxane-2,3,5,6,10,14,16-heptol,6-acetate, (2b,3b,6b,14R)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxane-2,3,5,6,10,14,16-heptol deriv.;
Rhodomollein III

grayanotoxane-5,6,7,10,16-pentol,2,3-epoxy-, (2b,3b,6b,7a)- (9CI);
LyoniolB (6CI);
5,7a-Methano-7aH-cyclohept[6,7]azuleno[1,2-b]oxirene,grayanotoxane-5,6,7,10,16-pentol deriv.;
Deacetyllyoniatoxin;
Deacetyllyoniol A

grayanotoxan-6-one,10,20-didehydro-3,5,14,16-tetrahydroxy-, (3b,14R)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalen-11(10H)-one,dodecahydro-2,8,11a,12-tetrahydroxy-1,1,8-trimethyl-4-methylene-,(2S,3aS,4aS,7R,8R,9aR,11aR,12R)- (8CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene, grayanotoxan-6-one deriv.;
6-Dehydrograyanotoxin II

grayanotoxa-10(20),16-diene-3,5,6,14-tetrol,14-acetate, (3b,6b,14R)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxa-10(20),16-diene-3,5,6,14-tetrol deriv.;
grayanotoxin X

grayanotoxane-3,5,6,10,14,16-hexol,14-propanoate, (3b,6b,14R)- (9CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxane-3,5,6,10,14,16-hexol deriv.;
Asebotoxin I;
Pierisformosin B

grayanotoxane-3,5,6,7,10,16-hexol,(3b,6b,7a)- (9CI);
7,9aa-Methano-9aH-cyclopenta[b]heptalene-2,4,8,10,11,11ab(1H)-hexol, 2a,3,3ab,4,4ab,5,6,7b,8,9,10b,11a-dodecahydro-1,1,4b,8b-tetramethyl- (8CI);
7,9a-Methano-9aH-cyclopenta[b]heptalene,grayanotoxane-3,5,6,7,10,16-hexol deriv.;
Dihydrodeacetyllyoniatoxin;
Dihydrolyoniol B;
Lyoniol B, dihydro-

grayanotox-10(20)-ene-3,5,6,14,16-pentol,14-acetate, (3b,6b,14R)-;
7,9a-Methano-9aH-cyclopenta[b]heptalene-2,8,11,11a,12(1H)-pentol,dodecahydro-1,1,8-trimethyl-4-methylene-, 12-acetate,(2S,3aS,4aS,7R,4aR,8R,9aS,11R,11aR,12R)-(-)- (8CI);
D10(18)-Andromedenol, acetate (7CI);
Acetylandromed-10(18)-enol;
grayanotoxin IV;
D10(18)-Acetylandromedenol

C22H34O6

详情

供应商

化工产品